Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Public Health | Research

Prevalence of tobacco use among cancer patients in Iran: a systematic review and meta-analysis

Authors: Mohammad Moein Vakilzadeh, Reza Khayami, Danyal Daneshdoust, Reza Moshfeghinia, Farzad Sharifnezhad, Zahra Taghiabadi, Hanieh Keikhay Moghadam, Mohammad Ali Karimi, Atousa Ghorbani, Pegah Bahrami Taqanaki, Nima Boojar, Adele Azarshab, Soodabeh Shahidsales, Reihaneh Alsadat Mahmoudian

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

The prevalence of tobacco use among various cancer types in Iran remains a significant concern, necessitating a comprehensive analysis to understand the extent and patterns of consumption. This study aimed to systematically review and analyze existing literature to delineate the prevalence of tobacco use across different cancer types in Iran, thereby providing a robust basis for future interventions and policy formulations.

Methods

Adhering to the PRISMA guidelines, we conducted a systematic review and meta-analysis of literature available in PubMed and Scopus databases. The initial search identified 351 records, out of which 44 studies were selected based on their relevance and design. These studies spanned various time frames, starting from the 2001s up until 2022, and encompassed diverse geographical locations and cancer types in Iran. To avoid bias and potential data overlap, we opted to incorporate a single comprehensive study from the Golestan Cohort, encompassing all data, while excluding 10 other studies. Our final analysis incorporated data from 34 studies, which accounted for 15,425 patients and 5,890 reported smokers. Statistical analyses were performed to calculate the overall proportion of tobacco consumption and to conduct subgroup analyses based on different variables such as cancer types, gender, geographical locations, and types of tobacco used.

Results

The analysis revealed a substantial prevalence of tobacco use among cancer patients in Iran, with an overall consumption rate of 43%. This rate varied significantly, ranging from 10 to 88% across individual studies. Subgroup analyses further highlighted disparities in tobacco consumption rates across different demographics, geographic areas, and cancer types. Notably, the ‘ever’ smokers category exhibited the highest prevalence of tobacco use. The study also identified a worrying trend of high cigarette smoking rates, along with variable consumption patterns of other forms of tobacco, including waterpipe, ‘Naas’, and ‘Pipe’.

Conclusions

This systematic review and meta-analysis underscores a significant association between tobacco consumption and various cancer types in Iran, with a prevalence rate among cancer patients being three times higher than the average Iranian population. The findings indicate substantial heterogeneity in tobacco use patterns, emphasizing the need for targeted interventions to address this pressing health issue. The study serves as a critical resource for shaping future policies and strategies aimed at curbing tobacco use and mitigating its adverse effects on cancer prevalence in Iran.
Literature
1.
go back to reference Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015;15(1):1–14.CrossRef Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015;15(1):1–14.CrossRef
2.
go back to reference Rafiemanesh H, Rajaei-Behbahani N, Khani Y, Hosseini S, Mohammadian-Hafshejani A, Soltani S, et al. Incidence trend and epidemiology of common cancers in the center of Iran. Global J Health Sci. 2016;8(3):146.CrossRef Rafiemanesh H, Rajaei-Behbahani N, Khani Y, Hosseini S, Mohammadian-Hafshejani A, Soltani S, et al. Incidence trend and epidemiology of common cancers in the center of Iran. Global J Health Sci. 2016;8(3):146.CrossRef
3.
go back to reference Roshandel G, Ferlay J, Ghanbari-Motlagh A, Partovipour E, Salavati F, Aryan K, et al. Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. Int J Cancer. 2021;149(3):594–605.PubMedCrossRef Roshandel G, Ferlay J, Ghanbari-Motlagh A, Partovipour E, Salavati F, Aryan K, et al. Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. Int J Cancer. 2021;149(3):594–605.PubMedCrossRef
4.
go back to reference Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg. 2006;391:603–13.PubMedCrossRef Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg. 2006;391:603–13.PubMedCrossRef
5.
go back to reference Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens—Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10(11):1033–4.PubMedCrossRef Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens—Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10(11):1033–4.PubMedCrossRef
6.
go back to reference Sitas F, Weber MF, Egger S, Yap S, Chiew M, O’Connell D. Smoking cessation after cancer. J Clin Oncol. 2014;32(32):3593–5.PubMedCrossRef Sitas F, Weber MF, Egger S, Yap S, Chiew M, O’Connell D. Smoking cessation after cancer. J Clin Oncol. 2014;32(32):3593–5.PubMedCrossRef
7.
go back to reference Zahra H, Mahshid A, Habib E, Mohammadreza M. Behavior and knowledge of Iranian professional athletes towards smoking. 2012. Zahra H, Mahshid A, Habib E, Mohammadreza M. Behavior and knowledge of Iranian professional athletes towards smoking. 2012.
8.
go back to reference Agudo A, Bonet C, Travier N, González CA, Vineis P, Bueno-de-Mesquita HB, et al. Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol. 2012;30(36):4550–7.PubMedCrossRef Agudo A, Bonet C, Travier N, González CA, Vineis P, Bueno-de-Mesquita HB, et al. Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol. 2012;30(36):4550–7.PubMedCrossRef
9.
go back to reference Halimi L, Haghdoost AA, Alizadeh SM. Prevalence of cigarette smoking among Iranian women: a systematic review and meta-analysis. Med J Islam Repub Iran. 2013;27(3):132.PubMedPubMedCentral Halimi L, Haghdoost AA, Alizadeh SM. Prevalence of cigarette smoking among Iranian women: a systematic review and meta-analysis. Med J Islam Repub Iran. 2013;27(3):132.PubMedPubMedCentral
10.
go back to reference Jose T, Schroeder DR, Warner DO. Changes in cigarette smoking behavior in cancer survivors during diagnosis and treatment. Nicotine Tob Res. 2022;24(10):1581–8.PubMedPubMedCentralCrossRef Jose T, Schroeder DR, Warner DO. Changes in cigarette smoking behavior in cancer survivors during diagnosis and treatment. Nicotine Tob Res. 2022;24(10):1581–8.PubMedPubMedCentralCrossRef
11.
go back to reference Vioque J, Barber X, Bolumar F, Porta M, Santibáñez M, de la Hera MG, et al. Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain. BMC Cancer. 2008;8(1):1–10.CrossRef Vioque J, Barber X, Bolumar F, Porta M, Santibáñez M, de la Hera MG, et al. Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain. BMC Cancer. 2008;8(1):1–10.CrossRef
12.
go back to reference Sasco A, Secretan M, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004;45:S3–9.PubMedCrossRef Sasco A, Secretan M, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004;45:S3–9.PubMedCrossRef
13.
go back to reference Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J Public Health. 2018;47(3):309.PubMedPubMedCentral Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J Public Health. 2018;47(3):309.PubMedPubMedCentral
14.
go back to reference Samet JM. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Cardiovasc Surg. 2013;23(2):103–12. Samet JM. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Cardiovasc Surg. 2013;23(2):103–12.
15.
go back to reference Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet. 2016;388(10062):e19–23.PubMedCrossRef Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet. 2016;388(10062):e19–23.PubMedCrossRef
16.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–94.PubMedCrossRef Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–94.PubMedCrossRef
17.
go back to reference Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046–67.PubMedCrossRef Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046–67.PubMedCrossRef
18.
go back to reference Wang Q. Dietary quality using four dietary indices and lung cancer risk: the Golestan Cohort Study (GCS). 2021. p. 493–503. Wang Q. Dietary quality using four dietary indices and lung cancer risk: the Golestan Cohort Study (GCS). 2021. p. 493–503.
19.
go back to reference Etemadi A. Hazards of cigarettes, smokeless tobacco and waterpipe in a Middle Eastern population: A cohort study of 50 000 individuals from Iran. 2017. p. 674–82. Etemadi A. Hazards of cigarettes, smokeless tobacco and waterpipe in a Middle Eastern population: A cohort study of 50 000 individuals from Iran. 2017. p. 674–82.
20.
go back to reference Sheikh M. Household fuel use and the risk of gastrointestinal cancers: The Golestan cohort study. 2020. p. 1–9. Sheikh M. Household fuel use and the risk of gastrointestinal cancers: The Golestan cohort study. 2020. p. 1–9.
21.
go back to reference Sheikh M. Individual and combined effects of environmental risk factors for esophageal cancer based on results from the Golestan cohort study. 2019. p. 1416–27. Sheikh M. Individual and combined effects of environmental risk factors for esophageal cancer based on results from the Golestan cohort study. 2019. p. 1416–27.
22.
go back to reference Rahmati A. Mortality from respiratory diseases associated with opium use: A population-based cohort study. 2017. p. 1028–34. Rahmati A. Mortality from respiratory diseases associated with opium use: A population-based cohort study. 2017. p. 1028–34.
23.
go back to reference Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, et al. Opium use and risk of pancreatic cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2018;27(3):268–73.PubMedCrossRef Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, et al. Opium use and risk of pancreatic cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2018;27(3):268–73.PubMedCrossRef
24.
go back to reference Nasrollahzadeh D. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. 2008. p. 1857–63. Nasrollahzadeh D. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. 2008. p. 1857–63.
25.
go back to reference Marjani HA. Prevalence of esophageal cancer risk factors among Turkmen and non-Turkmen ethnic groups in a high incidence area in Iran. 2010. p. 111–5. Marjani HA. Prevalence of esophageal cancer risk factors among Turkmen and non-Turkmen ethnic groups in a high incidence area in Iran. 2010. p. 111–5.
26.
go back to reference Aghcheli K. Prognostic factors for esophageal squamous cell Carcinoma-a population-based study in Golestan province, Iran, a high incidence area. 2011.CrossRef Aghcheli K. Prognostic factors for esophageal squamous cell Carcinoma-a population-based study in Golestan province, Iran, a high incidence area. 2011.CrossRef
27.
go back to reference Abnet CC. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. 2004. p. 1068–70. Abnet CC. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. 2004. p. 1068–70.
28.
go back to reference Sheikh M. Opium use and subsequent incidence of cancer: results from the Golestan cohort study. 2020. Sheikh M. Opium use and subsequent incidence of cancer: results from the Golestan cohort study. 2020.
29.
go back to reference Mahouri KH. Breast cancer risk factors in south of Islamic Republic of Iran: A case-control study. 2007. p. 1265–73. Mahouri KH. Breast cancer risk factors in south of Islamic Republic of Iran: A case-control study. 2007. p. 1265–73.
30.
go back to reference Abdolahinia Z, Pakmanesh H, Mirzaee M, Bazrafshan A, Bafti MS, Shahesmaeili A. Opium and cigarette smoking are independently associated with bladder cancer: the findings of a matched case - control study. Asian Pac J Cancer Prev. 2021;22(10):3385–91.PubMedPubMedCentralCrossRef Abdolahinia Z, Pakmanesh H, Mirzaee M, Bazrafshan A, Bafti MS, Shahesmaeili A. Opium and cigarette smoking are independently associated with bladder cancer: the findings of a matched case - control study. Asian Pac J Cancer Prev. 2021;22(10):3385–91.PubMedPubMedCentralCrossRef
31.
go back to reference Ahmadi M. Epidemiologic and socioeconomic status of bladder cancer in Mazandaran province, northern Iran. 2012. p. 5053–6. Ahmadi M. Epidemiologic and socioeconomic status of bladder cancer in Mazandaran province, northern Iran. 2012. p. 5053–6.
32.
go back to reference Akbari M. Opium as a risk factor for bladder cancer: A population-based case-control study in Iran. 2015. p. 567–71. Akbari M. Opium as a risk factor for bladder cancer: A population-based case-control study in Iran. 2015. p. 567–71.
33.
go back to reference Moghadam TN, Mirzaee M, Bahrampour A, Jahani Y, Abbasi MH. Survival Analysis of gastric cancer patients using illness-death model in Kerman City, Southeast Iran during 2001–2016. Middle East J Dig Dis. 2021;13(3):208–15.CrossRef Moghadam TN, Mirzaee M, Bahrampour A, Jahani Y, Abbasi MH. Survival Analysis of gastric cancer patients using illness-death model in Kerman City, Southeast Iran during 2001–2016. Middle East J Dig Dis. 2021;13(3):208–15.CrossRef
34.
go back to reference Rafati S, Baneshi MR, Bahrampour A. Factors affecting long-survival of patients with breast cancer by non-mixture and mixture cure models using the Weibull, log-logistic and Dagum distributions: a Bayesian approach. Asian Pac J Cancer Prev. 2020;21(2):485–90.PubMedPubMedCentralCrossRef Rafati S, Baneshi MR, Bahrampour A. Factors affecting long-survival of patients with breast cancer by non-mixture and mixture cure models using the Weibull, log-logistic and Dagum distributions: a Bayesian approach. Asian Pac J Cancer Prev. 2020;21(2):485–90.PubMedPubMedCentralCrossRef
35.
go back to reference Samadi F. Survival rate of gastric and esophageal cancers in Ardabil Province, North-West of Iran. 2007. p. 32–7. Samadi F. Survival rate of gastric and esophageal cancers in Ardabil Province, North-West of Iran. 2007. p. 32–7.
36.
go back to reference Hadji M. The Iranian Study of Opium and Cancer (IROPICAN): Rationale, design, and initial findings. 2021. p. 167–76. Hadji M. The Iranian Study of Opium and Cancer (IROPICAN): Rationale, design, and initial findings. 2021. p. 167–76.
37.
go back to reference Momtahen S. Assessment of gynecologic malignancies: A multi-center study in Tehran (1995–2005). 2009. p. 226–30. Momtahen S. Assessment of gynecologic malignancies: A multi-center study in Tehran (1995–2005). 2009. p. 226–30.
38.
go back to reference Hosseini B, Olsson A, Bouaoun L, Hall A, Hadji M, Rashidian H, et al. Lung cancer risk in relation to jobs held in a nationwide case-control study in Iran. Occup Environ Med. 2022;79(12):831–8.PubMedCrossRef Hosseini B, Olsson A, Bouaoun L, Hall A, Hadji M, Rashidian H, et al. Lung cancer risk in relation to jobs held in a nationwide case-control study in Iran. Occup Environ Med. 2022;79(12):831–8.PubMedCrossRef
39.
go back to reference Fayez EA, Moosavi SAJ, Kouranifar S, Delbandi AA, Teimourian S, Khoshmirsafa M, et al. The effect of smoking on latent tuberculosis infection susceptibility in high risk individuals in Iran. J Immunoassay Immunochem. 2020;41(5):885–95.CrossRef Fayez EA, Moosavi SAJ, Kouranifar S, Delbandi AA, Teimourian S, Khoshmirsafa M, et al. The effect of smoking on latent tuberculosis infection susceptibility in high risk individuals in Iran. J Immunoassay Immunochem. 2020;41(5):885–95.CrossRef
40.
go back to reference Aminisani N, Nikbakht HA, Hosseinei SR, Shamshirgaran SM. Adverse health behaviours among colorectal cancer survivors: a case study from Iran. J Gastrointest Oncol. 2016;7(3):373–9.PubMedPubMedCentralCrossRef Aminisani N, Nikbakht HA, Hosseinei SR, Shamshirgaran SM. Adverse health behaviours among colorectal cancer survivors: a case study from Iran. J Gastrointest Oncol. 2016;7(3):373–9.PubMedPubMedCentralCrossRef
41.
go back to reference Andisheh-Tadbir A. Sociodemographic and etiological differences of head and neck squamous cell carcinoma in young and old patients in southern Iran. 2010. p. 126–8. Andisheh-Tadbir A. Sociodemographic and etiological differences of head and neck squamous cell carcinoma in young and old patients in southern Iran. 2010. p. 126–8.
42.
go back to reference Azimi S. Socioeconomic determinants as risk factors for squamous cell carcinoma of the head and neck: a case-control study in Iran. 2018. p. 304–9. Azimi S. Socioeconomic determinants as risk factors for squamous cell carcinoma of the head and neck: a case-control study in Iran. 2018. p. 304–9.
43.
go back to reference Khademi H. Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: A 7-year cross-sectional study. 2012. Khademi H. Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: A 7-year cross-sectional study. 2012.
44.
go back to reference Khoshbaten M, Naderpour M, Mohammadi G, Alipoor SH, Estakhri R, Fazeli Z. Epidemiology of esophageal lesions in patients with head and neck squamous cell carcinoma. Asian Pac J Cancer Prev. 2010;11(4):863–5.PubMed Khoshbaten M, Naderpour M, Mohammadi G, Alipoor SH, Estakhri R, Fazeli Z. Epidemiology of esophageal lesions in patients with head and neck squamous cell carcinoma. Asian Pac J Cancer Prev. 2010;11(4):863–5.PubMed
45.
go back to reference Mafi N, Kadivar M, Hosseini N, Ahmadi S, Zare-Mirzaie A. Head and neck squamous cell carcinoma in Iranian patients and risk factors in young adults: a fifteen-year study. Asian Pac J Cancer Prev. 2012;13(7):3373–8.PubMedCrossRef Mafi N, Kadivar M, Hosseini N, Ahmadi S, Zare-Mirzaie A. Head and neck squamous cell carcinoma in Iranian patients and risk factors in young adults: a fifteen-year study. Asian Pac J Cancer Prev. 2012;13(7):3373–8.PubMedCrossRef
46.
go back to reference Mahouri K, Zahedani MD, Zare S. Breast cancer risk factors in south of Islamic Republic of Iran: a case-control study. East Mediterr Health J. 2007;13(6):1265–73.PubMedCrossRef Mahouri K, Zahedani MD, Zare S. Breast cancer risk factors in south of Islamic Republic of Iran: a case-control study. East Mediterr Health J. 2007;13(6):1265–73.PubMedCrossRef
47.
go back to reference Mashhadi MA. High prevalence of esophageal cancer in South-East of Iran. 2011. p. 18–21. Mashhadi MA. High prevalence of esophageal cancer in South-East of Iran. 2011. p. 18–21.
48.
go back to reference Masjedi MR. Opium could be considered an independent risk factor for lung cancer: A case-control study. 2013. p. 112–8. Masjedi MR. Opium could be considered an independent risk factor for lung cancer: A case-control study. 2013. p. 112–8.
49.
go back to reference Mohebbi E, Hadji M, Rashidian H, Rezaianzadeh A, Marzban M, Haghdoost AA, et al. Opium use and the risk of head and neck squamous cell carcinoma. Int J Cancer. 2021;148(5):1066–76.PubMedCrossRef Mohebbi E, Hadji M, Rashidian H, Rezaianzadeh A, Marzban M, Haghdoost AA, et al. Opium use and the risk of head and neck squamous cell carcinoma. Int J Cancer. 2021;148(5):1066–76.PubMedCrossRef
50.
go back to reference Sanat ZM, Masoudi S, Mansouri M, Shishavan NG, Jameshorani M, Pourshams A. Diabetes mellitus, obesity, and risk of pancreatic ductal adenocarcinoma: a large case-control study from Iran. Middle East J Dig Dis. 2021;13(1):15–20.CrossRef Sanat ZM, Masoudi S, Mansouri M, Shishavan NG, Jameshorani M, Pourshams A. Diabetes mellitus, obesity, and risk of pancreatic ductal adenocarcinoma: a large case-control study from Iran. Middle East J Dig Dis. 2021;13(1):15–20.CrossRef
51.
go back to reference Motovali-Bashi M. Role of CYP1A1 MspI polymorphism in CYP1A1 gene with susceptibility to lung cancer in Iranian patients. 2012. Motovali-Bashi M. Role of CYP1A1 MspI polymorphism in CYP1A1 gene with susceptibility to lung cancer in Iranian patients. 2012.
52.
go back to reference Naghibzadeh-Taham A. Can opium use contribute to a higher risk of colorectal cancers? A matched case-control study in Iran. 2016. p. 1322–31. Naghibzadeh-Taham A. Can opium use contribute to a higher risk of colorectal cancers? A matched case-control study in Iran. 2016. p. 1322–31.
53.
go back to reference Nikbakht H. Trends in the incidence of colorectal cancer and epidemiologic and clinical characteristics of survivors in Babol city in 2007–2012. 2015. p. 7–14. Nikbakht H. Trends in the incidence of colorectal cancer and epidemiologic and clinical characteristics of survivors in Babol city in 2007–2012. 2015. p. 7–14.
54.
go back to reference Pournaghi S. Tobacco consumption, opium use, alcohol drinking and the risk of esophageal cancer in North Khorasan, Iran. 2019. p. 105–9. Pournaghi S. Tobacco consumption, opium use, alcohol drinking and the risk of esophageal cancer in North Khorasan, Iran. 2019. p. 105–9.
55.
go back to reference Sadjadi A, Derakhshan MH, Yazdanbod A, Boreiri M, Parsaeian M, Babaei M, et al. Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions. Int J Cancer. 2014;134(1):181–8.PubMedCrossRef Sadjadi A, Derakhshan MH, Yazdanbod A, Boreiri M, Parsaeian M, Babaei M, et al. Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions. Int J Cancer. 2014;134(1):181–8.PubMedCrossRef
56.
go back to reference Saedi B, Razmpa E, Sadeghi M, Mojtahed M, Mojtahed A. The epidemiology of laryngeal cancer in a country on the esophageal cancer belt. Indian J Otolaryngol Head Neck Surg. 2009;61(3):213–7.PubMedPubMedCentralCrossRef Saedi B, Razmpa E, Sadeghi M, Mojtahed M, Mojtahed A. The epidemiology of laryngeal cancer in a country on the esophageal cancer belt. Indian J Otolaryngol Head Neck Surg. 2009;61(3):213–7.PubMedPubMedCentralCrossRef
57.
go back to reference Salehi A, Khezri AA, Malekmakan L, Aminsharifi A. Epidemiologic status of bladder cancer in Shiraz, southern Iran. Asian Pac J Cancer Prev. 2011;12(5):1323–7.PubMed Salehi A, Khezri AA, Malekmakan L, Aminsharifi A. Epidemiologic status of bladder cancer in Shiraz, southern Iran. Asian Pac J Cancer Prev. 2011;12(5):1323–7.PubMed
58.
go back to reference Sheikh M, Shakeri R, Poustchi H, Pourshams A, Etemadi A, Islami F, et al. Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. Lancet Glob Health. 2020;8(5):e649–60.PubMedPubMedCentralCrossRef Sheikh M, Shakeri R, Poustchi H, Pourshams A, Etemadi A, Islami F, et al. Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. Lancet Glob Health. 2020;8(5):e649–60.PubMedPubMedCentralCrossRef
59.
go back to reference Shivappa N. Dietary Inflammatory Index and Risk of Esophageal Squamous Cell Cancer in a Case-Control Study from Iran. 2015. p. 1255–61. Shivappa N. Dietary Inflammatory Index and Risk of Esophageal Squamous Cell Cancer in a Case-Control Study from Iran. 2015. p. 1255–61.
60.
go back to reference Simonian M. Environmental risk factors associated with sporadic colorectal cancer in Isfahan, Iran. 2018. p. 318–22. Simonian M. Environmental risk factors associated with sporadic colorectal cancer in Isfahan, Iran. 2018. p. 318–22.
61.
go back to reference Tabei SZ, Heydari ST, Mehrabani D, Shamsina SJ, Ahmadi J, Firouzi SM. Current substance use in patients with gastric cancer in Southern Iran. J Cancer Res Ther. 2006;2(4):182–5.PubMedCrossRef Tabei SZ, Heydari ST, Mehrabani D, Shamsina SJ, Ahmadi J, Firouzi SM. Current substance use in patients with gastric cancer in Southern Iran. J Cancer Res Ther. 2006;2(4):182–5.PubMedCrossRef
62.
go back to reference Tarrahi MJ. Lung cancer occurrence in Southern Iran. 2009. p. 139–40. Tarrahi MJ. Lung cancer occurrence in Southern Iran. 2009. p. 139–40.
63.
go back to reference Vazirinejad R, Najafipour R, Rezaeian M, Ghazizadeh A, Mohammadi FD. Opium and risk of gastrointestinal cancer: a case-control study. Turk J Med Sci. 2020;50(4):697–705.PubMedPubMedCentralCrossRef Vazirinejad R, Najafipour R, Rezaeian M, Ghazizadeh A, Mohammadi FD. Opium and risk of gastrointestinal cancer: a case-control study. Turk J Med Sci. 2020;50(4):697–705.PubMedPubMedCentralCrossRef
64.
go back to reference Abbasi-Kangevari M, Ghanbari A, Fattahi N, Malekpour M-R, Masinaei M, Ahmadi N, et al. Tobacco consumption patterns among Iranian adults: a national and sub-national update from the STEPS survey 2021. Sci Rep. 2023;13(1):10272.PubMedPubMedCentralCrossRef Abbasi-Kangevari M, Ghanbari A, Fattahi N, Malekpour M-R, Masinaei M, Ahmadi N, et al. Tobacco consumption patterns among Iranian adults: a national and sub-national update from the STEPS survey 2021. Sci Rep. 2023;13(1):10272.PubMedPubMedCentralCrossRef
65.
go back to reference Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155–64.PubMedCrossRef Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155–64.PubMedCrossRef
66.
go back to reference Sohrabi MR, Abbasi-Kangevari M, Kolahi AA. Current tobacco smoking prevalence among Iranian population: A closer look at the STEPS surveys. Front Public Health. 2020;8:571062.PubMedPubMedCentralCrossRef Sohrabi MR, Abbasi-Kangevari M, Kolahi AA. Current tobacco smoking prevalence among Iranian population: A closer look at the STEPS surveys. Front Public Health. 2020;8:571062.PubMedPubMedCentralCrossRef
Metadata
Title
Prevalence of tobacco use among cancer patients in Iran: a systematic review and meta-analysis
Authors
Mohammad Moein Vakilzadeh
Reza Khayami
Danyal Daneshdoust
Reza Moshfeghinia
Farzad Sharifnezhad
Zahra Taghiabadi
Hanieh Keikhay Moghadam
Mohammad Ali Karimi
Atousa Ghorbani
Pegah Bahrami Taqanaki
Nima Boojar
Adele Azarshab
Soodabeh Shahidsales
Reihaneh Alsadat Mahmoudian
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Public Health
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18594-8

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue